Cancel

Artificial intelligence in ocular medicine

 
Artificial intelligence in ocular medicine: Seeing into the future
In April 2018, the FDA approved the first Artificial Intelligence (AI) enabled device to detect “more than mild diabetic retinopathy.” Globally, additional AI devices have been approved for use in ophthalmic clinics and more are in development. Despite these advances, many clinicians and researchers are unaware of how the technology works, what technology has been approved for clinical use or is in the development pipeline and how to integrate these potential technologies into their research or clinical practice. Researchers face many challenges when developing these algorithms and moving the resulting products from the lab to the clinic.
 

 
Start:
June 13, 2019
End:
July 1, 2019
Calendar:
Location:
ARVO Online Education Event

Contact

WGA Executive Office
Schipluidenlaan 4
1062 HE Amsterdam
The Netherlands
+31 20 570 96 00
info@worldglaucoma.org

World Glaucoma Association

www.worldglaucoma.org
Follow WGA on Facebook
Follow WGA on Twitter

World Glaucoma Congress

www.worldglaucomacongress.org

WGA.ONE

www.wga.one
My WGA.one profile

International Glaucoma Review

www.e-igr.com

World Glaucoma Week

www.worldglaucomaweek.org
Cancel